ENP
ENTRONEURO FPO [ENP]
Healthcare · ASX Small Cap
$0.0340 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +1First seen: 2026-02-25
Score Breakdown
Technical45
Catalyst51
Sentiment50
Fundamental37
Momentum43
Risk Gate30
Active Signals
Bullish Signals
- OBV divergence: accumulation detected
- Critical cash runway (1.6 quarters)
- Small-cap ($20-100M)
- Altman Z-Score in distress zone (1.43 < 1.81)
- Low-priced stock risk ($0.034)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD bearish crossover
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Application for quotation of securities - ENP
NONE Appendix 4D and Half Year Report for period 31 Dec 2025
NONE Update to Appendix 3B
Recent ASX Announcements
| 2026-03-02 | Application for quotation of securities - ENP |
| 2026-02-26 | Appendix 4D and Half Year Report for period 31 Dec 2025 PRICE SENSITIVE |
| 2026-02-16 | Update to Appendix 3B |
| 2026-02-11 | Australian Patent Secures TRP 8803 Platform to 2042 PRICE SENSITIVE |
| 2026-02-08 | 2026 EGM Letter of Access, Notice of Meeting and Proxy |
Key Metrics
$54.9M
Market Cap
2.9M
Avg Volume
1.0x
Vol Ratio
$0.03 — $0.04
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-92.1%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 64% |
| L | Leader vs Laggard | neutral | RS: 1 |
| I | Institutional Sponsorship | weak | Inst: 5% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #92 of 119 · Sector avg: 51
View all Healthcare signals →